Publication
Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study - Study protocol.
S Anderson, M C Douglas, R Valentine, L Grocutt, G J Inman, L Hay, S Wright, K Mair, C Kelly, R Seddon, A Shaw, MacMillan A, J Gourlay, J Flach, E Au, C Vens, C Schoenherr, D Grose, C Lamb, S Schipani, S Vohra, C Wilson, C Paterson
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: The incidence of head and neck squamous cell cancer (HNSCC), including HPV-positive and negative oropharyngeal squamous cell cancer (OPSCC) is rising. HPV-negative and some HPV-positive OPSCC has poor outcomes. Attempts to uniformly intensify treatment in poor-prognosis HNSCC…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Oropharyngeal Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available